Literature DB >> 10354514

Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain.

J Wally1, G Kica, Y Zhang, T Ericsson, L H Connors, M D Benson, J J Liepnieks, J Murray, M Skinner, R L Comenzo.   

Abstract

Current concepts regarding the association between immunoglobulin (Ig) light chain structure and AL amyloidosis (AL) emphasize Ig variable region amino acid substitutions because the majority of light chain amyloid fibrils that have been sequenced contain amino termini of the variable region with only small amounts of the constant region. In this report, we describe a patient with rapidly progressive AL whose amyloid deposits contained primarily monoclonal kappa light chain constant region fragments. We sequenced and analyzed this AL protein, determining that it was an O18-O8 kappa1 variant and that the constant region possessed an unusual Ser-->Asn substitution at position 177. Using pre-mortem bone marrow cells, we cloned and sequenced the cDNA for this AL protein (HCAK1) and, using DNA from post-mortem somatic tissue, we cloned and sequenced the patient's kappa germline O18-O8 donor and kappa constant region (Ckappa) gene segments. The cDNA that coded for HCAK1 contained a variable region that was derived from O18-O8, showing 96.1% homology to germline, and a Ckappa that had a nucleotide substitution (AGC to AAC), resulting in the 177Ser-->Asn replacement. Two Ckappa genes were cloned from somatic tissue DNA, one identical to a known Ckappa sequence and another containing this substitution which likely is a new Ckappa allotype. Our findings indicate that further investigation is warranted into the contributions genetic polymorphisms and light chain constant regions may make to amyloidogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354514     DOI: 10.1016/s0925-4439(99)00019-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Thermodynamic stability of a kappaI immunoglobulin light chain: relevance to multiple myeloma.

Authors:  Connie M Chung; Jenny D Chiu; Lawreen H Connors; Olga Gursky; Amareth Lim; Andrew B Dykstra; Juris Liepnieks; Merrill D Benson; Catherine E Costello; Martha Skinner; Mary T Walsh
Journal:  Biophys J       Date:  2005-03-25       Impact factor: 4.033

2.  A father and his son with systemic AL amyloidosis.

Authors:  Stina Enqvist; Ulf-Henrik Mellqvist; Johan Mölne; Knut Sletten; Charles Murphy; Alan Solomon; Fred J Stevens; Per Westermark
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

3.  Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.

Authors:  Yoshinobu Hoshii; Hidemi Nanbara; Dan Cui; Mutsuo Takahashi; Eiji Ikeda
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

Review 4.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.

Authors:  Batia Kaplan; Brian M Martin; Olga Boykov; Rivka Gal; Mordechai Pras; Itzhak Shechtman; Milton Saute; Mordechai R Kramer
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.

Authors:  Stina Enqvist; Knut Sletten; Fred J Stevens; Ulf Hellman; Per Westermark
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

7.  Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?

Authors:  Sarah Cappuyns; Matthias Verbesselt; Alexander Van De Bruaene; Jan Bogaert; Lucienne Michaux; Michel Delforge
Journal:  Eur Heart J Case Rep       Date:  2022-02-17

8.  Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.

Authors:  Tanya L Poshusta; Laura A Sikkink; Nelson Leung; Raynell J Clark; Angela Dispenzieri; Marina Ramirez-Alvarado
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.